Literature DB >> 14505229

Log-linear models for assessing gene-age interaction and their application to case-control studies of the apolipoprotein E (apoE) gene in Alzheimer's disease.

Noriko Tanaka1, Toru Kinoshita2, Takashi Asada3, Yasuo Ohashi4.   

Abstract

Case-control studies provide a powerful approach for detecting disease-susceptibility genes or assessing gene-environment interactions. We investigated the situation in which the gene being studied plays a role in several diseases, and the allele frequency among subjects free of the disease of interest consequently decreases with age as subjects die from other diseases. The logistic model is one approach frequently used for analyzing case-control data, but it cannot accommodate this dependence of genotype and age. Using a log-linear model, we therefore proposed a hierarchical procedure that could be used as a valid method for assessing interactions in such situations. We then applied this procedure to observed data on Alzheimer's disease and the apolipoprotein E gene in Japan. We were able to derive an appropriate inference on whether the interaction was a gene-age interaction or merely a bias due to death from other diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505229     DOI: 10.1007/s10038-003-0069-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  11 in total

1.  Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study.

Authors:  T Ou; K Yamakawa-Kobayashi; T Arinami; H Amemiya; H Fujiwara; K Kawata; M Saito; S Kikuchi; Y Noguchi; Y Sugishita; H Hamaguchi
Journal:  Atherosclerosis       Date:  1998-03       Impact factor: 5.162

2.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?

Authors:  R M Corbo; R Scacchi
Journal:  Ann Hum Genet       Date:  1999-07       Impact factor: 1.670

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19.

Authors:  D S Borgaonkar; L C Schmidt; S E Martin; M D Kanzer; L Edelsohn; J Growdon; L A Farrer
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

5.  Apolipoprotein E allele in centenarians.

Authors:  T Asada; T Kariya; Z Yamagata; T Kinoshita; A Asaka
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

6.  Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes.

Authors:  T Asada; T Motonaga; Z Yamagata; M Uno; K Takahashi
Journal:  Sleep       Date:  2000-08-01       Impact factor: 5.849

7.  Designing and analysing case-control studies to exploit independence of genotype and exposure.

Authors:  D M Umbach; C R Weinberg
Journal:  Stat Med       Date:  1997-08-15       Impact factor: 2.373

8.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.

Authors:  P W Wilson; R H Myers; M G Larson; J M Ordovas; P A Wolf; E J Schaefer
Journal:  JAMA       Date:  1994-12-07       Impact factor: 56.272

9.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Authors:  E H Corder; A M Saunders; N J Risch; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  2 in total

Review 1.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Populations. Additional Analyses on Type-2 Diabetes Risk.

Authors:  Jose V Sorlí; Rocío Barragán; Oscar Coltell; Olga Portolés; Eva C Pascual; Carolina Ortega-Azorín; José I González; Ramon Estruch; Carmen Saiz; Alejandro Pérez-Fidalgo; Jose M Ordovas; Dolores Corella
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.